United Orthopedic Corporation

TPEX:4129 Stock Report

Market Cap: NT$8.9b

United Orthopedic Past Earnings Performance

Past criteria checks 4/6

United Orthopedic has been growing earnings at an average annual rate of 46.7%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 14.4% per year. United Orthopedic's return on equity is 12%, and it has net margins of 10.1%.

Key information

46.7%

Earnings growth rate

43.7%

EPS growth rate

Medical Equipment Industry Growth11.5%
Revenue growth rate14.4%
Return on equity12.0%
Net Margin10.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Calculating The Fair Value Of United Orthopedic Corporation (GTSM:4129)

Apr 26
Calculating The Fair Value Of United Orthopedic Corporation (GTSM:4129)

United Orthopedic (GTSM:4129) Could Be Struggling To Allocate Capital

Apr 12
United Orthopedic (GTSM:4129) Could Be Struggling To Allocate Capital

What Type Of Returns Would United Orthopedic's(GTSM:4129) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Mar 08
What Type Of Returns Would United Orthopedic's(GTSM:4129) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Is United Orthopedic (GTSM:4129) A Risky Investment?

Feb 16
Is United Orthopedic (GTSM:4129) A Risky Investment?

Does United Orthopedic Corporation (GTSM:4129) Have A Place In Your Dividend Stock Portfolio?

Jan 29
Does United Orthopedic Corporation (GTSM:4129) Have A Place In Your Dividend Stock Portfolio?

Our Take On The Returns On Capital At United Orthopedic (GTSM:4129)

Jan 11
Our Take On The Returns On Capital At United Orthopedic (GTSM:4129)

Does United Orthopedic Corporation's (GTSM:4129) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

Dec 24
Does United Orthopedic Corporation's (GTSM:4129) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

How Much Did United Orthopedic's(GTSM:4129) Shareholders Earn From Share Price Movements Over The Last Five Years?

Dec 03
How Much Did United Orthopedic's(GTSM:4129) Shareholders Earn From Share Price Movements Over The Last Five Years?

Revenue & Expenses Breakdown

How United Orthopedic makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:4129 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244,4714542,680211
30 Jun 244,2754282,522189
31 Mar 244,0684072,414184
31 Dec 233,9303802,323185
30 Sep 233,7213422,174178
30 Jun 233,5463082,092188
31 Mar 233,3572521,969180
31 Dec 223,1692221,847167
30 Sep 222,9731731,752155
30 Jun 222,832981,685149
31 Mar 222,684701,595141
31 Dec 212,571291,538144
30 Sep 212,520441,521151
30 Jun 212,551781,513157
31 Mar 212,446861,456153
31 Dec 202,342781,402155
30 Sep 202,310361,386176
30 Jun 202,240131,363177
31 Mar 202,396561,452189
31 Dec 192,437841,468188
30 Sep 192,3931311,446179
30 Jun 192,3271321,398180
31 Mar 192,3201161,343187
31 Dec 182,3321281,316200
30 Sep 182,2771001,255216
30 Jun 182,2841071,249225
31 Mar 182,1871601,187217
31 Dec 171,9731301,062199
30 Sep 171,803139953181
30 Jun 171,577106831163
31 Mar 171,39361713160
31 Dec 161,383147659161
30 Sep 161,379138649165
30 Jun 161,407186651165
31 Mar 161,437198658157
31 Dec 151,393134655152
30 Sep 151,330135610142
30 Jun 151,271113578133
31 Mar 151,14372559129
31 Dec 141,10182535127
30 Sep 141,04452520121
30 Jun 1499725495125
31 Mar 1498531476127
31 Dec 1395621457124

Quality Earnings: 4129 has high quality earnings.

Growing Profit Margin: 4129's current net profit margins (10.1%) are higher than last year (9.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4129's earnings have grown significantly by 46.7% per year over the past 5 years.

Accelerating Growth: 4129's earnings growth over the past year (32.7%) is below its 5-year average (46.7% per year).

Earnings vs Industry: 4129 earnings growth over the past year (32.7%) exceeded the Medical Equipment industry 1.7%.


Return on Equity

High ROE: 4129's Return on Equity (12%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 16:10
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

United Orthopedic Corporation is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pinghan HsiehCapital Securities Corporation
Jennie TsaiG. Research, LLC
Zhennan LeeJih Sun Securities Investment Consulting Co., Ltd.